SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
AGRI BIO-SCIENCES, INC.
_______________________________________
(Name of Issuer)
Common Stock
_______________________________________
(Title of Class of Securities)
00849V106
_______________________________________
(CUSIP Number)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
CUSIP NO. 00849V106
(1) Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
Vernon L. Medlin, M.D.
(2) Check the Appropriate Box if a Member of a Group* (a) ____
(b) ____
(3) SEC Use Only ______________________________
(4) Citizenship or Place of Organization
United States of America
Number of shares beneficially owned by each reporting person with:
(5) Sole voting power 568,000
(6) Shared voting power 625,000
(7) Sole dispositive power 568,000
(8) Shared dispositive power 625,000
(9) Aggregate amount beneficially
owned by each reporting person 1,193,000
(10) Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)
__________________________________________________________
(11) Percent of class represented by amount in Row (9) 10.5%
(12) Type of reporting person (see instructions) IN
Item 1(a) Name of issuer:
Agri Bio-Sciences, Inc.
Item 1(b) Address of issuer's principal executive offices:
5211 Court of York, Houston, Texas 77069
Item 2(a) Name of Person(s) Filing:
Vernon L. Medlin, M.D.
Item 2(b) Address of Principal Business Office:
1242 Sandpiper, Corpus Christi, Texas 78412
Item 2(c) Citizenship or Place of Organization:
United States of America
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number: 00849V106
Item 3 Not applicable.
Item 4 Ownership. Provide the following information regarding the
aggregate number and percentage of the class of securities of
the issuer identified in Item 1.
(a) Amount Beneficially Owned:
1,193,000
(b) Percent of class:
10.5%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
568,000
(ii) Shared power to vote or to direct the vote:
625,000
(iii) Sole power to dispose or to direct the disposition
of:
568,000
(iv) Shared power to dispose or to direct the disposition
of:
625,000
Item 5 Ownership of Five Percent or Less of a Class. If this statement is
being filed to report the fact that as of the date hereof the
reporting person has ceased to be the beneficial owner of
more than 5 percent of the class of securities, check the
following [ ].
Item 6 Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company.
Not applicable.
Item 8 Identification and Classification of Members of the Group.
Not applicable.
Item 9 Notice of Dissolution of Group.
Not applicable.
Item 10 Certification.
Not applicable.
Signature. After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this statement is
true, complete and correct.
Dated: February 9, 2000
/s/ Vernon L. Medlin, M.D.
Vernon L. Medlin, M.D.
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative other than an executive
officer or general partner of the filing person, evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
Note
Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
for whom copies are to be sent.
Attention
Intentional misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).
